Latest News for: jnj

Edit

JNJ Raised the Bar: So Why Is the Stock Standing Still (Insight Guru Inc)

Public Technologies 12 Jun 2026
) JNJ Raised the Bar ... JNJ ... Let's talk about the meeting of two very different signals in Johnson & Johnson (JNJ) stock ... JNJ Stock Insights So, Where's The Reward? ... Relevant Articles Why Did Wall Street Misprice JNJ Stock? Pay Less, Gain More.
Edit

What Could Push JNJ Stock Higher From Here (Insight Guru Inc)

Public Technologies 12 Jun 2026
) What Could Push JNJ Stock Higher From Here? ... JNJ ... Excluding the legacy drug, Johnson & Johnson (JNJ) grew in double digits for the quarter ... JNJ ... Relevant Articles JNJ Raised the Bar ... JNJ Stock Insights How Compounding Builds The Upside.
Edit

Why Did Wall Street Misprice JNJ Stock (Insight Guru Inc)

Public Technologies 11 Jun 2026
) Why Did Wall Street Misprice JNJ Stock? ... JNJ ... can the company fill the multi-billion-dollar hole? In the case of Johnson & Johnson (JNJ), the market seemed to be bracing for a slog ... JAZZ Delivers More JNJ Stock's 60% Breakout.
Edit

Johnson & Johnson (JNJ) Stock Rises on Positive Nipocalimab Lupus Trial Data

BitRSS 03 Jun 2026
Johnson & Johnson (JNJ) stock gains as nipocalimab ...
Edit

Final Trade: JNJ, SMH, APA

CNBC 19 May 2026
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders ... .
Edit

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer (Form 6-K) (Nanobiotix SA)

Public Technologies 18 May 2026
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer ... (JNJ-90301900) ... About JNJ-1900 (NBTXR3).
Edit

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer (Nanobiotix SA)

Public Technologies 17 May 2026
Radiographic Response in Patients with Stage III Unresectable Non-Small Cell Lung Cancer Treated with an Intratumoral Radioenhancer (JNJ-90301900) ... About JNJ-1900 (NBTXR3). JNJ-1900 (NBTXR3) is a novel, ...
Edit

Pay Less, Gain More: LLY, JNJ Top Viatris Stock (Insight Guru Inc)

Public Technologies 14 May 2026
LLY, JNJ Top Viatris Stock ... LLY, JNJ are Viatris's peers in Pharmaceuticals industry that have. ... This disconnect between valuation and performance could mean that you are better off buying LLY, JNJ stocks vs ... Metric VTRS LLY JNJ.
Edit

Is JNJ Stock Setup For A Rerating (Insight Guru Inc)

Public Technologies 11 May 2026
) Is JNJ Stock Setup For A Rerating? ... JNJ ... Johnson & Johnson (JNJ) stock trades at $222.51 per share, a market cap of $536.0B, and 25.5 times trailing earnings ... Where JNJ Sits Today Valuation ... JNJ ... JAZZ Delivers More JNJ Stock's 60% Breakout.
Edit

Final Trade: DAL, HNGE, Mag 7, JNJ

CNBC 06 May 2026
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders ... .
Edit

Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease

PR Newswire 05 May 2026
"By targeting the orthogonal pathways of IL-23 and TNFα, JNJ-4804 yields a synergistic therapeutic approach ... Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson.
Edit

Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease (Johnson & Johnson)

Public Technologies 05 May 2026
"By targeting the orthogonal pathways of IL-23 and TNFα, JNJ-4804 yields a synergistic therapeutic approach ... Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson.
Edit

Final Trade: CME, JNJ, AFRM, WMT

CNBC 03 Apr 2026
The final trades of the day with the 'Fast Money' traders ... .
Edit

JNJ Stock’s 60% Breakout: Why Wall Street is Torn (Insight Guru Inc)

Public Technologies 02 Apr 2026
) JNJ Stock's 60% Breakout ... JNJ ... Johnson & Johnson (JNJ) stock is up 62% over the last twelve months ... JNJ stock has strong momentum ... Why Bet On JNJ Now? ... The big question for JNJ investors right now is this.
Edit

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 ...

The Daily Record - Dunn 30 Mar 2026
Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference PARIS and CAMBRIDGE, Mass., March ....

Article Search

tools
×
×
×
×